IPA COPYRIGHT: ASHP A brief overview of some new drugs recently introduced in the United States is presented: midodrine hydrochloride (Proamatine), miglitol (Glyset), mirtazapine (Remeron), nelfinavir mesylate (Viracept), nevirapine (Viramune), nilutamide (Nilandron), olanzapine (Zyprexa), olopatadine hydrochloride (Patanol), penciclovir (Denavir), pentosan polysulfate sodium (Elmiron), pramipexole dihydrochloride (Mirapex), reteplase (Retavase), ropinirole hydrochloride (Requip), ropivacaine hydrochloride (Naropin), sparfloxacin (Zagam), tamsulosin hydrochloride (Flomax), tiludronate disodium (Skelid), tizanidine hydrochloride (Zanaflex), topiramate (Topamax), trandolapril (Mavik), troglitazone (Rezulin), valsartan (Diovan), zafirlukast (Accolate), and zileuton (Zyflo). This article qualifies for 1.5 hours U.S. CE credit by the ACPE.